High Disease Burden

BOSTON — When presented with the statement, “I have trouble keeping up with my family, friends, children and/or grandchildren because of IPF” via online survey, 49% agreed, according to a poster presented at the CHEST Annual Meeting.

Children and young adults with relapsed or refractory B-cell acute lymphoblastic leukemia increasingly receive tisagenlecleucel in earlier settings when they have lower disease burden, according to findings presented at ASCO Annual Meeting.